JP2007520506A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007520506A5 JP2007520506A5 JP2006551761A JP2006551761A JP2007520506A5 JP 2007520506 A5 JP2007520506 A5 JP 2007520506A5 JP 2006551761 A JP2006551761 A JP 2006551761A JP 2006551761 A JP2006551761 A JP 2006551761A JP 2007520506 A5 JP2007520506 A5 JP 2007520506A5
- Authority
- JP
- Japan
- Prior art keywords
- concomitant drug
- drug according
- daily dose
- formoterol
- glycopyrrolate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 claims 23
- 229940079593 drug Drugs 0.000 claims 12
- 229960002848 formoterol Drugs 0.000 claims 7
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 claims 7
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 claims 6
- 229940015042 glycopyrrolate Drugs 0.000 claims 6
- 229960004017 salmeterol Drugs 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- 239000013543 active substance Substances 0.000 claims 4
- 208000023504 respiratory system disease Diseases 0.000 claims 3
- 229940127230 sympathomimetic drug Drugs 0.000 claims 3
- 229940000425 combination drug Drugs 0.000 claims 2
- 238000004806 packaging method and process Methods 0.000 claims 2
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 239000000443 aerosol Substances 0.000 claims 1
- 230000007815 allergy Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 239000003607 modifier Substances 0.000 claims 1
- 230000000414 obstructive effect Effects 0.000 claims 1
- 230000002085 persistent effect Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000003380 propellant Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 230000002459 sustained effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54195704P | 2004-02-06 | 2004-02-06 | |
| US60/541,957 | 2004-02-06 | ||
| PCT/EP2005/000649 WO2005074900A2 (en) | 2004-02-06 | 2005-01-24 | NOVEL COMBINATION OF ANTICHOLINERGIC AND β MIMETICS FOR THE TREATMENT OF RESPIRATORY DISEASES |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007520506A JP2007520506A (ja) | 2007-07-26 |
| JP2007520506A5 true JP2007520506A5 (enExample) | 2008-02-14 |
| JP5524442B2 JP5524442B2 (ja) | 2014-06-18 |
Family
ID=34837534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006551761A Expired - Fee Related JP5524442B2 (ja) | 2004-02-06 | 2005-01-24 | 呼吸器疾患の治療のための、抗コリン作用薬及びβ−模倣薬の新規併用薬 |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US20050175549A1 (enExample) |
| EP (1) | EP1718336B1 (enExample) |
| JP (1) | JP5524442B2 (enExample) |
| CN (1) | CN1905902A (enExample) |
| AT (1) | ATE399027T1 (enExample) |
| AU (1) | AU2005210083B2 (enExample) |
| CA (1) | CA2550841C (enExample) |
| CY (1) | CY1108326T1 (enExample) |
| DE (1) | DE602005007708D1 (enExample) |
| DK (1) | DK1718336T3 (enExample) |
| ES (1) | ES2309705T3 (enExample) |
| HR (1) | HRP20080439T3 (enExample) |
| NO (1) | NO337128B1 (enExample) |
| NZ (1) | NZ548302A (enExample) |
| PL (1) | PL1718336T3 (enExample) |
| PT (1) | PT1718336E (enExample) |
| RU (1) | RU2438660C2 (enExample) |
| SI (1) | SI1718336T1 (enExample) |
| WO (1) | WO2005074900A2 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
| JP4819699B2 (ja) * | 2004-02-06 | 2011-11-24 | メダ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト | 喘息及びｃｏｐｄの長期間の治療のための抗コリン作用薬及びグルココルチコイドの組合せ剤 |
| GB0410398D0 (en) * | 2004-05-10 | 2004-06-16 | Arakis Ltd | The treatment of respiratory disease |
| ES2257152B1 (es) * | 2004-05-31 | 2007-07-01 | Laboratorios Almirall S.A. | Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos. |
| DE602006008665D1 (de) * | 2005-12-21 | 2009-10-01 | Meda Pharma Gmbh & Co Kg | Kombination von r,r-glycopyrrolat, rolipram und budesonid zur behandlung von entzündungskrankheiten |
| US20080031828A1 (en) * | 2006-08-03 | 2008-02-07 | Boehringer Ingelheim International Gmbh | Method for the Treatment of Dyspnea Comprising Combined Administration of Tiotropium Salts and Salts of Salmeterol |
| EP1944018A1 (en) * | 2007-01-10 | 2008-07-16 | CHIESI FARMACEUTICI S.p.A. | Micronised particles of low-dosage strength active agents for powder formulations for inhalation |
| GB0801876D0 (en) * | 2008-02-01 | 2008-03-12 | Vectura Group Plc | Suspension formulations |
| US20100055045A1 (en) * | 2008-02-26 | 2010-03-04 | William Gerhart | Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations |
| GB2468073B (en) * | 2008-02-26 | 2012-09-05 | Elevation Pharmaceuticals Inc | Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations |
| EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| EP2221048A1 (en) | 2009-02-18 | 2010-08-25 | Siegfried Generics International AG | Pharmaceutical composition for inhalation |
| US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
| SI3106149T1 (sl) * | 2009-05-29 | 2020-07-31 | Pearl Therapeutics, Inc. | Sestavki za pljučno dostavo muskarinskih antagonistov z dolgotrajnim delovanjem in agonistov beta-2 adrenergičnega receptorja z dolgotrajnim delovanjem in povezani postopki in sistemi |
| WO2010144628A2 (en) * | 2009-06-09 | 2010-12-16 | Elevation Pharmaceuticals, Inc. | Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration |
| TWI495468B (zh) | 2009-12-23 | 2015-08-11 | 吉斯藥品公司 | 治療慢性阻塞性肺病（ｃｏｐｄ）之醫藥組成物 |
| CN102665678B (zh) * | 2009-12-23 | 2014-07-02 | 奇斯药制品公司 | 用于copd的联合治疗 |
| KR101747474B1 (ko) * | 2009-12-23 | 2017-06-14 | 키에시 파르마슈티시 엣스. 피. 에이. | Ｃｏｐｄ용 에어로졸 제제 |
| RU2567040C2 (ru) * | 2009-12-23 | 2015-10-27 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Аэрозольная препаративная форма для лечения по поводу хронического обструктивного легочного заболевания |
| RU2013142268A (ru) | 2011-02-17 | 2015-03-27 | Сипла Лимитед | Фармацевтическая композиция |
| JO3510B1 (ar) | 2011-03-04 | 2020-07-05 | Heptares Therapeutics Ltd | استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب |
| EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
| MX2013013440A (es) * | 2011-05-17 | 2014-06-05 | Pearl Therapeutics Inc | Composiciones, metodos y sistemas para suministro respiratorio de dos o mas agentes activos. |
| HK1219059A1 (zh) | 2013-03-15 | 2017-03-24 | 珍珠治疗公司 | 用於微粒晶体材料的状态调节的方法和系统 |
| WO2015101576A1 (en) | 2013-12-30 | 2015-07-09 | Chiesi Farmaceutici S.P.A. | Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination |
| CN105848642A (zh) * | 2013-12-30 | 2016-08-10 | 奇斯药制品公司 | 格隆溴铵和福莫特罗组合的稳定的加压气雾剂溶液组合物 |
| WO2017077488A1 (en) * | 2015-11-04 | 2017-05-11 | Glenmark Pharmaceuticals Limited | An inhalable fixed dose powder composition comprising glycopyrronium and formoterol |
| EP4069189A1 (en) | 2019-12-02 | 2022-10-12 | Chiesi Farmaceutici S.p.A. | Stainles steel can for pressurised metered dose inhalers |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0932401A1 (en) * | 1996-07-01 | 1999-08-04 | Sepracor, Inc. | Methods and compositions for treating urinary incontinence using enantiomerically enriched (r,r)-glycopyrrolate |
| DK0937041T3 (da) | 1996-11-11 | 2003-08-11 | Christian R Noe | Anvendelse af et farmaceutisk egnet salt af (3R,2'R)-3-[(cyclopentil-hydroxyphenylacetyl)oxyl]-1,1-dimethyl-pyrrolidinium til fremstilling af et lægemiddel |
| US6585958B1 (en) | 1998-07-24 | 2003-07-01 | Jago Research Ag | Medicinal aerosol formulations |
| AU749697B2 (en) * | 1998-08-04 | 2002-07-04 | Jagotec Ag | Medicinal aerosol formulations |
| CA2347856C (en) * | 1998-11-13 | 2009-02-17 | Jagotec Ag | Dry powder for inhalation |
| DE19921693A1 (de) * | 1999-05-12 | 2000-11-16 | Boehringer Ingelheim Pharma | Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika |
| US20040002548A1 (en) * | 1999-05-12 | 2004-01-01 | Boehringer Ingelheim Pharma Kg | Medicament compositions containing anticholinergically-effective compounds and betamimetics |
| DE19961300A1 (de) * | 1999-12-18 | 2001-06-21 | Asta Medica Ag | Vorratssystem für Arzneimittel in Pulverform und damit ausgestatteter Inhalator |
| GB0008660D0 (en) * | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
| GB0008485D0 (en) * | 2000-04-07 | 2000-05-24 | Glaxo Group Ltd | Pharmaceutical compositions |
| PT1372608E (pt) * | 2001-03-30 | 2008-01-04 | Jagotec Ag | Formulações de aerossol médicas |
| US6667344B2 (en) * | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
-
2005
- 2005-01-24 EP EP05701139A patent/EP1718336B1/en not_active Expired - Lifetime
- 2005-01-24 DE DE602005007708T patent/DE602005007708D1/de not_active Expired - Lifetime
- 2005-01-24 JP JP2006551761A patent/JP5524442B2/ja not_active Expired - Fee Related
- 2005-01-24 RU RU2006132036/15A patent/RU2438660C2/ru not_active Application Discontinuation
- 2005-01-24 PT PT05701139T patent/PT1718336E/pt unknown
- 2005-01-24 AT AT05701139T patent/ATE399027T1/de active
- 2005-01-24 ES ES05701139T patent/ES2309705T3/es not_active Expired - Lifetime
- 2005-01-24 HR HR20080439T patent/HRP20080439T3/xx unknown
- 2005-01-24 CN CNA2005800019327A patent/CN1905902A/zh active Pending
- 2005-01-24 AU AU2005210083A patent/AU2005210083B2/en not_active Ceased
- 2005-01-24 CA CA2550841A patent/CA2550841C/en not_active Expired - Fee Related
- 2005-01-24 NZ NZ548302A patent/NZ548302A/en not_active IP Right Cessation
- 2005-01-24 PL PL05701139T patent/PL1718336T3/pl unknown
- 2005-01-24 SI SI200530323T patent/SI1718336T1/sl unknown
- 2005-01-24 WO PCT/EP2005/000649 patent/WO2005074900A2/en not_active Ceased
- 2005-01-24 DK DK05701139T patent/DK1718336T3/da active
- 2005-02-07 US US11/051,469 patent/US20050175549A1/en not_active Abandoned
-
2006
- 2006-07-11 US US11/483,693 patent/US20060252815A1/en not_active Abandoned
- 2006-08-31 NO NO20063882A patent/NO337128B1/no not_active IP Right Cessation
-
2007
- 2007-07-30 US US11/882,109 patent/US7985766B2/en active Active
-
2008
- 2008-09-10 CY CY20081100967T patent/CY1108326T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007520506A5 (enExample) | ||
| RU2006132036A (ru) | Комбинация и фармацевтический препарат для лечения аллергий и заболеваний дыхательных путей | |
| Chan et al. | Advances in device and formulation technologies for pulmonary drug delivery | |
| JP2011520911A5 (enExample) | ||
| JP2022180461A5 (enExample) | ||
| HRP20130835T1 (hr) | Farmaceutske formulacije otopine za davanje kao stlaäśeni inhalat u inhalatoru | |
| RU2019100425A (ru) | Новая доза и препаративная форма | |
| MX2023001592A (es) | Inhalador de polvo seco. | |
| RU2006132038A (ru) | Комбинация (варианты) и фармацевтический препарат для лечения заболеваний дыхательных путей | |
| JP2019517542A5 (enExample) | ||
| JP2010518122A5 (enExample) | ||
| BR0317443A (pt) | Medicamento pulverulento para inalação contendo um sal de tiotrópio e xinafoato de salmeterol | |
| BRPI0518622A2 (pt) | usos de antagonistas de receptor do tipo 1 de interleucina-1(il-1r1) para a fabricaÇço de um medicamento para o tratamento de uma doenÇa respiratària; composiÇço farmacÊutica que compreende um antagonista do il-1r1 e um veÍculo fisiologicamente aceitÁvel e dispositivo de liberaÇço de medicamento | |
| BR0008699A (pt) | Combinações de formoterol e furoato demometasona para asma | |
| WO2005084638A3 (en) | Formulations decreasing infectivity of pulmonary diseases | |
| JP2007520508A5 (enExample) | ||
| JP2009269923A5 (enExample) | ||
| JP2018513188A5 (enExample) | ||
| JP2014514271A5 (enExample) | ||
| JP2007520507A5 (enExample) | ||
| JP2005508963A5 (enExample) | ||
| JP2017527608A (ja) | 経鼻組成物と該経鼻組成物の使用方法の改善 | |
| AR039408A1 (es) | Composicion farmaceutica en polvo seco para terapia por inhalacion y uso para fabricacion de un medicamento | |
| JP2005508963A (ja) | 喘息を治療するためのサルメテロールとフルチカゾンプロピオネートを含む医薬の組み合せ | |
| CN106488770A (zh) | 用于治疗copd的福莫特罗和布地奈德的组合 |